Christian Loesche, Damien Picard, Benjamin Van Hoorick, Imelda Schuhmann, Petra Jäger, Kai Klein, . . . Till A. Röhn. (2024). LTA4H inhibitor LYS006: Clinical PK/PD and safety in a randomized phase I clinical trial. Wiley.
Chicago Style (17th ed.) CitationChristian Loesche, et al. LTA4H Inhibitor LYS006: Clinical PK/PD and Safety in a Randomized Phase I Clinical Trial. Wiley, 2024.
MLA (9th ed.) CitationChristian Loesche, et al. LTA4H Inhibitor LYS006: Clinical PK/PD and Safety in a Randomized Phase I Clinical Trial. Wiley, 2024.
Warning: These citations may not always be 100% accurate.